SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors

INTRODUCTION: The COVID‐19 vaccine was designed to provide protection against infection by the severe respiratory coronavirus 2 (SARS‐CoV‐2) and coronavirus disease 2019 (COVID‐19). However, the vaccine's efficacy can be compromised in patients with immunodeficiencies or the vaccine‐induced imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Taborska, Pavla, Lastovicka, Jan, Stakheev, Dmitry, Strizova, Zuzana, Bartunkova, Jirina, Smrz, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427053/
https://www.ncbi.nlm.nih.gov/pubmed/34314576
http://dx.doi.org/10.1002/iid3.496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427053/
https://www.ncbi.nlm.nih.gov/pubmed/34314576
http://dx.doi.org/10.1002/iid3.496

Ejemplares similares